RxDoctor Payments Data

Sridharan Gururangan

Pediatric Hematology-Oncology · Gainesville, FLNPI 1124102033

Payments from drug & device makers

What this record shows

Every reported general payment came from a single manufacturer, Bristol Myers Squibb.

$1,666in general payments, 2019–2025

Across 4 payments — averaging $416.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$2K
$798,916in research payments, 2019–2025

Across 43 payments — averaging $18,579 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$432K
  • Regeneron$234K
  • E.r. Squibb & Sons, L.L.C.$100K
  • Bristol Myers Squibb$33K

What the payments were for

  • Travel & lodging$96758%
  • Food & beverage$69942%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb4$1,666

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,666 in reported general payments places this provider in the 65th percentile of 132 pediatric hematology-oncology providers in Florida.

See all pediatric hematology-oncology providers in Florida

Other pediatric hematology-oncology in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →